Studying Cancer Metastasis Potential by In-Vivo Flow Cytometry and Imaging

Guangda Liu,Jin Guo,Yan Li,Zhichao Fan

DOI: https://doi.org/10.1109/acp.2010.5682512

2010-01-01

Abstract:An in vivo flow cytometer and optical imaging are used to assess tumor cell spreading. The depletion rate of circulating tumor cells provides insights in early cancer metastasis. It is useful to understand the molecular mechanisms of tumor metastasis.

What problem does this paper attempt to address?

Studying leukemia metastasis by in vivo imaging and flow cytometer

Xunbin Wei,Yun Chen,Yan Li,Li Zhang,Guangda Liu

DOI: https://doi.org/10.1364/aoe.2008.sun3

2009-01-01

Abstract:A recently developed ldquoin vivo flow cytometerrdquo and optical imaging are used to assess leukemic cell spreading and the circulation kinetics, as well as assess the effectiveness of the potential therapeutic interventions.
Studying tumor metastasis by in vivo imaging and flow cytometer

Xunbin Wei,Jin Guoa,Guangda Liu,Yan Li,Yun Chen,Li Zhang,Yuan Tan,Tong Chen,Zhenqin Gu,Chen Wang

DOI: https://doi.org/10.1117/12.808610

2009-01-01

Abstract:Liver cancer is one of the most common malignancies in the world, with approximately 1,000,000 cases reported every year. This ranges from 15,000 cases in the United States to more than a 250,000 in China. About 80% of people with primary liver cancer are male. Although two-thirds of people have advanced liver disease when they seek medical help, one third of the patients have cancer that has not progressed beyond the liver. Primary liver cancer (hepatocellular carcinoma, or HCC) is associated with liver cirrhosis 60-80% of the time. HCC may metastasize to the lung, bones, kidney, and many other organs. Surgical resection, liver transplantation, chemotherapy and radiation therapy are the foundation of current HCC therapies. However the outcomes are poor: the survival rate is almost zero for metastatic HCC patients. Molecular mechanisms of HCC metastasis need to be understood better and new therapies must be developed to selectively target to unique characteristics of HCC cell growth and metastasis. We have developed the "in vivo microscopy" to study the mechanisms that govern liver tumor cell spread through the microenvironment in vivo in real-time confocal near-infrared fluorescence imaging. A recently developed "in vivo flow cytometer" and optical imaging are used to assess liver tumor cell spreading and the circulation kinetics of liver tumor cells. A real-time quantitative monitoring of circulating liver tumor cells by the in vivo flow cytometer will be useful to assess the effectiveness of the potential therapeutic interventions.
Monitoring Hepatocellular Carcinoma Metastasis by in Vivo Flow Cytometer

Yan Li,Jin Guo,Guangda Liu,Chen Wang,Zhengqin Gu,Xunbin Wei

DOI: https://doi.org/10.1117/12.843459

2010-01-01

Abstract:A recently developed "in vivo flow cytometer" and optical imaging are used to assess liver tumor cell spreading and the circulation kinetics of liver tumor cells. The in vivo flow cytometer has the capability to detect and quantify the number and flow characteristics of fluorescently labeled cells in vivo continuously. The depletion rate of circulating tumor cells provides insights in early cancer metastasis. It is useful to understand the molecular mechanisms of liver tumor metastasis. A real-time quantitative monitoring of circulating liver tumor cells by the in vivo flow cytometer will help assess the effectiveness of the potential therapeutic interventions.
In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Zhichao Fan,Xunbin Wei

DOI: https://doi.org/10.1515/plm-2012-0043

2013-01-01

Photonics and Lasers in Medicine

Abstract:AbstractOptical methods have revolutionized medical diagnoses, therapies and research, and have penetrated many medical disciplines for example, tumor diagnosis and treatment. Tumor recurrence and metastasis are the major obstacles for long-term survival in cancer. The metastasis is reported to be correlated with the presence of circulating tumor cells (CTCs) in the vasculature as a consequence of either advanced tumor growth and invasion, or a therapeutic intervention. Thus, CTCs are considered to be important biomarkers for cancer progress and prognosis. The quantification of CTCs is an emerging tool used to diagnose, stratify and monitor patients with metastatic diseases. A number of methods have been developed to detect CTCs, some of which have been applied in clinical diagnosis. However, conventional methods are restricted by invasiveness, lower sensitivity caused by small blood sample volumes, and difficulty in recording the dynamics of CTCs. A novel technique named
Studying Depletion Kinetics Of Circulating Prostate Cancer Cells By In Vivo Flow Cytometer

Guangda Liu,Zhengqin Gu,Jin Guo,Yan Li,Yun Chen,Tong Chen,Cheng Wang,Xunbin Wei

DOI: https://doi.org/10.1117/12.877100

2011-01-01

Abstract:Prostate cancer is the most common malignancy in American men and the second leading cause of deaths from cancer, after lung cancer. The tumor usually grows slowly and remains confined to the gland for many years. During this time, the tumor produces little or no symptoms or outward signs. As the cancer advances, however, it can metastasize throughout other areas of the body, such as the bones, lungs, and liver. Surgical resection, hormonal therapy, chemotherapy and radiation therapy are the foundation of current prostate cancer therapies. Treatments for prostate cause both short- and long-term side effects that may be difficult to accept. Molecular mechanisms of prostate cancer metastasis need to be understood better and new therapies must be developed to selectively target to unique characteristics of cancer cell growth and metastasis. We have developed the "in vivo microscopy" to study the mechanisms that govern prostate cancer cell spread through the microenvironment in vivo in real-time confocal near-infrared fluorescence imaging. A recently developed "in vivo flow cytometer" and optical imaging are used to assess prostate cancer cell spreading and the circulation kinetics of prostate cancer cells. A real-time quantitative monitoring of circulating prostate cancer cells by the in vivo flow cytometer will be useful to assess the effectiveness of the potential therapeutic interventions.
Monitoring Circulating Tumor Cells by In-Vivo Flow Cytometry

Xiaoling Wang,Xunbin Wei

DOI: https://doi.org/10.1364/acpc.2016.af3k.2

2016-01-01

Abstract:An in vivo flow cytometer is used to monitoring circulating tumor cells. The counting of circulating tumor cells provides insights in early cancer metastasis. It is useful to understand the molecular mechanisms of tumor metastasis.
Studying Circulation Times of Liver Cancer Cells by in Vivo Flow Cytometry

G. Liu,Y. Li,Z. Fan,J. Guo,X. Tan,X. Wei

DOI: https://doi.org/10.1088/1742-6596/276/1/012005

2011-01-01

Journal of Physics Conference Series

Abstract:Hepatocellular carcinoma (HCC) may metastasize to lung, bones, kidney, and many other organs. The survival rate is almost zero for metastatic HCC patients. Molecular mechanisms of HCC metastasis need to be understood better and new therapies must be developed. A recently developed "in vivo flow cytometer" combined with real-time confocal fluorescence imaging are used to assess spreading and the circulation kinetics of liver tumor cells. The in vivo flow cytometer has the capability to detect and quantify continuously the number and flow characteristics of fluorescently labeled cells in vivo in real time without extracting blood sample. We have measured the depletion kinetics of two related human HCC cell lines, high-metastatic HCCLM3 cells and low-metastatic HepG2 cells, which were from the same origin and obtained by repetitive screenings in mice. >60% HCCLM3 cells are depleted within the first hour. Interestingly, the low-metastatic HepG2 cells possess noticeably slower depletion kinetics. In comparison, <40% HepG2 cells are depleted within the first hour. The differences in depletion kinetics might provide insights into early metastasis processes.
In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

I Georgakoudi,N Solban,J Novak,WL Rice,XB Wei,T Hasan,CP Lin

DOI: https://doi.org/10.1364/bio.2004.thc6

2004-01-01

Abstract:The fate of circulating tumor cells is an important determinant of their ability to form distant metastasis. Here, we demonstrate the use of in vivo flow cytometry as a powerful new method for detecting quantitatively circulating cancer cells. We specifically examine the circulation kinetics of two prostate cancer cell lines with different metastatic potential in mice and rats. We find that the cell line and the host environment affect the circulation kinetics of prostate cancer cells, with the intrinsic cell line properties determining the initial rate of cell depletion from the circulation and the host affecting cell circulation at later time points.
Monitoring Tumor Metastasis by in Vivo Imaging and Flow Cytometer

Zhenqin Gu,Jin Guo,Guangda Liu,Yan Li,Yun Chen,Tong Chen,Chen Wang,Xunbin Wei

DOI: https://doi.org/10.1117/12.843637

2009-01-01

Abstract:Prostate cancer is the most common malignancy in American men and the second leading cause of deaths from cancer, after lung cancer. The tumor usually grows slowly and remains confined to the gland for many years. During this time, the tumor produces little or no symptoms or outward signs. As the cancer advances, however, it can metastasize throughout other areas of the body, such as the bones, lungs, and liver. Surgical resection, hormonal therapy, chemotherapy and radiation therapy are the foundation of current prostate cancer therapies. Treatments for prostate cause both short- and long-term side effects that may be difficult to accept. Molecular mechanisms of prostate cancer metastasis need to be understood better and new therapies must be developed to selectively target to unique characteristics of cancer cell growth and metastasis. We have developed the "in vivo microscopy" to study the mechanisms that govern prostate cancer cell spread through the microenvironment in vivo in real-time confocal nearinfrared fluorescence imaging. A recently developed "in vivo flow cytometer" and optical imaging are used to assess prostate cancer cell spreading and the circulation kinetics of prostate cancer cells. A real- time quantitative monitoring of circulating prostate cancer cells by the in vivo flow cytometer will be useful to assess the effectiveness of the potential therapeutic interventions.
Applications of Optical in Vivo Flow Cytometry in Tumor Metastasis Research(Invited)

Zhang Fuli,Tian Huaqin,Li Hongliang,Wei Xunbin

DOI: https://doi.org/10.3788/lop232407

2024-01-01

Laser & Optoelectronics Progress

Abstract:Cancer poses a significant threat to human health,with tumor invasion and metastasis being the leading causes of mortality.Circulating tumor cells(CTCs)and other circulating entities are pivotal in the metastasis process.Consequently,tracking these cells and particles is critical for understanding metastasis.Optical in vivo flow cytometry(IVFC),an innovative laser-based technique,facilitates non-invasive tracking of CTCs and tumor-associated particles,proving invaluable in cancer researches,especially in metastasis studies.This study focuses on the applications of IVFC in tumor metastasis research.We discuss the detection principles of IVFC,highlighting various optical techniques such as fluorescence emission,photoacoustic effects,and computer vision.The categorization of IVFC technologies,including fluorescence in vivo flow cytometry,photoacoustic flow cytometry,and in vivo imaging flow cytometry,is detailed.We review its application in research on different cancers such as liver,prostate,breast cancer,and melanoma.The paper concludes with future prospects for IVFC in studying tumor metastasis.
Advances of In Vivo Flow Cytometry on Cancer Studies

Yuanzhen Suo,Zhenqin Gu,Xunbin Wei

DOI: https://doi.org/10.1002/cyto.a.23851

IF: 4.714

2019-07-05

Cytometry Part A

Abstract:Cancer is a big threat to human life. Asia has about 60% of the global population and accounts for half of global cancer incidence and mortality. Circulating tumor cells (CTCs) have been a good biomarker for cancer diagnosis, staging, and prognosis. Conventional detection methods of CTCs require drawing blood. It may disturb the biological environment and limited real‐time monitoring. in vivo flow cytometry (IVFC) is a burgeoning technique that allows noninvasive detection of CTCs in vivo. Here, we review the technical development of IVFC based on various contrast principles, including fluorescence IVFC, photoacoustic IVFC, imaging IVFC, and label‐free IVFC. This powerful tool has been applied widely in many areas of cancer‐related studies, especially the CTC studies. We review applications of IVFC in preclinical studies on prevalent cancers in Asia, including liver cancer, blood cancer, and so forth. Other cancer‐related studies in breast cancer, prostate cancer, cancer‐related stem cell research and drug studies are also reviewed. © 2019 International Society for Advancement of Cytometry

cell biology,biochemical research methods
Studying leukemia metastasis and therapy monitoring by in vivo imaging and flow cytometer

xunbin wei,yan li,yuan tan,li zhang,yun chen,guangda liu,tong chen,zhenqin gu,guiying wang,zenghui zhou,li wang,chen wang

DOI: https://doi.org/10.1117/12.757830

2008-01-01

Abstract:Cytotoxic chemotherapy agents are the foundation of current leukemia therapy. For a large number of adult and elderly patients, however, treatment options are poor. These patients may suffer from disease that is resistant to conventional chemotherapy or may not be candidates for curative therapies because of advanced age or poor medical conditions. To control disease in these patients, new therapies must be developed that are selectively targeted to unique characteristics of leukemic cell growth and metastasis. A large body of elegant work in the field of immunology has demonstrated the mechanisms whereby leukocytes traffic to specific sites within the body. Vascular cell adhesion molecules and chemicalattractants combine to direct white blood cells to appropriate environments. Although it has been hypothesized that leukemic white blood cells home to hematopoietic organs using mechanisms similar to those of their benign leukocyte counterparts, detailed study of leukemic cell transit through bone marrow has yet to be undertaken. We develop the "in vivo microscopy" to study the mechanisms that govern leukemic cell spread through the bone marrow microenvironment in vivo in real-time confocal infrared fluorescence imaging. A recently developed "in vivo flow cytometer" and optical imaging are used to assess leukemic cell spreading and the circulation kinetics of leukemic cells. A real-time quantitative monitoring of circulating leukemic cells by the in vivo flow cytometer will be useful to assess the effectiveness of the potential therapeutic interventions.
Studying the Role of Macrophages in Circulating Prostate Cancer Cells by in Vivo Flow Cytometry

Rongrong Liu,Jin Guo,Zhengqin Gu,Xunbin Wei

DOI: https://doi.org/10.1117/12.2003598

2010-01-01

Abstract:Prostate cancer is the most common malignancy in American men and the second leading cause of deaths from cancer, after lung cancer. The tumor usually grows slowly and remains confined to the gland for many years. During this time, the tumor produces little or no symptoms or outward signs. As the cancer advances, however, it can metastasize throughout other areas of the body, such as the bones, lungs, and liver. Surgical resection, hormonal therapy, chemotherapy and radiation therapy are the foundation of current prostate cancer therapies. Treatments for prostate cause both short-and long-term side effects that may be difficult to accept. Molecular mechanisms of prostate cancer metastasis need to be understood better and new therapies must be developed to selectively target to unique characteristics of cancer cell growth and metastasis. We have developed the "in vivo microscopy" to study the mechanisms that govern prostate cancer cell spread through the microenvironment in vivo in real-time confocal near-infrared fluorescence imaging. A recently developed "in vivo flow cytometer" and optical imaging are used to assess prostate cancer cell spreading and the circulation kinetics of prostate cancer cells. A real-time quantitative monitoring of circulating prostate cancer cells by the in vivo flow cytometer will be useful to assess the effectiveness of the potential therapeutic interventions.
In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells

Dan Wei,Zhichao Fan,Xueding Wang,Xunbin Wei

DOI: https://doi.org/10.1117/12.2003620

2013-01-01

Abstract:Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, with approximately 1,000,000 cases reported every year. The fate of circulating tumor cells (CTCs) is an important determinant of metastasis and recurrence, which lead to most deaths in HCC. Therefore, quantification of CTCs proves to be an emerging tool for diagnosing, stratifying and monitoring patients with metastatic diseases. In vivo flow cytometry (IVFC) has the capability to monitor the dynamics of fluorescently labeled CTCs continuously and non-invasively. Here, we combine IVFC technique and a GFP-transfected HCC orthotopic metastatic tumor model to monitor CTC dynamics. Our IVFC has ~1.8-fold higher sensitivity than whole blood analysis by conventional flow cytometry. We find out a significant difference of CTC dynamics between orthotopic and subcutaneous (s.c.) tumor models. We also investigate whether liver resection promotes or restricts hematogenous metastasis in advanced HCC. Our result shows that the number of CTCs and early metastases decreases after the resection. CTC dynamics is correlated with tumor growth in our orthotopic tumor model. The number and size of distant metastases correspond to CTC dynamics. The novel IVFC technique combined with orthotopic tumor models might provide insights to tumor hematogenous metastasis and guidance to cancer therapy.
Noninvasive and real-time monitoring of Au nanoparticle promoted cancer metastasis using in vivo flow cytometry

Wen Pang,Shihui Ding,Liyun Lin,Chen Wang,Man Lei,Jiale Xu,Xintong Wang,Junle Qu,Xunbin Wei,Bobo Gu

DOI: https://doi.org/10.1364/boe.420123

IF: 3.4

2021-03-02

Biomedical Optics Express

Abstract:Cancer is the second leading cause of mortality globally, while cancer metastasis, which accounts for about 90% of cancer-related mortality, presents an extremely poor prognosis. Thus, various nanomedicines were designed and synthesized for cancer treatment, but nanomaterials could lead to endothelial leakiness and consequently facilitate intravasation and extravasation of cancer cells to form circulating tumor cells (CTCs), which were regarded as the potential metastatic seeds, possibly accelerating cancer metastasis. Neither possible metastatic sites were observed nor rare CTCs could be measured using common methods at the early stage of cancer metastasis, it is urgent to explore new technology to dynamically monitor nanomedicine promoted cancer metastasis with high sensitivity, which would be beneficial for cancer treatment as well as design and synthesis of nanomedicine. Herein, a novel optical biopsy tool i.e. in vivo flow cytometry (IVFC) was constructed to noninvasively and real-time monitor CTCs of tumor-bearing mice treated with various concentrations of Au nanoparticles. The in vivo experimental results demonstrated the promoted CTCs were Au nanoparticles dose-dependent consistent with the in vitro results, which showed Au nanoparticles induced dose-dependent gaps in the blood vessel endothelial walls to accelerate CTCs formation, making IVFC a promising biopsy tool in fundamental, pre-clinical and clinical investigation of nanomedicine and cancer metastasis.

radiology, nuclear medicine & medical imaging,biochemical research methods,optics
Visualizing Interactions of Circulating Tumor Cell and Dendritic Cell in the Blood Circulation Using in Vivo Imaging Flow Cytometry

Dan Wei,Xuejiao Zeng,Zhangru Yang,Quanyu Zhou,Xiaofu Weng,Hao He,Wenyuan Gao,Zhengqin Gu,Xunbin Wei

DOI: https://doi.org/10.1109/tbme.2019.2891068

IF: 4.6

2019-01-01

IEEE Transactions on Biomedical Engineering

Abstract:Objective: Visualizing cell interactions in blood circulation is of great importance in studies of anticancer immunotherapy or drugs. However, the lack of a suitable imaging system hampers progress in this field. Methods: In this work, we built a dual-channel in vivo imaging flow cytometer to visualize the interactions of circulating tumor cells (CTCs) and dendritic cells (DCs) simultaneously in the bloodstream. Two artificial neural networks were trained to identify blood vessels and cells in the acquired images. Results and Conclusion: Using this technique, single CTCs and CTC clusters were readily distinguished by their morphology. Interactions of CTCs and DCs were identified, while their moving velocities were analyzed. The CTC-DC clusters moved at a slower velocity than that of single CTCs or DCs. This may provide new insights into tumor metastasis and blood rheology. Significance: This in vivo imaging flow cytometry system holds great potential for assessing the efficiency of targeting CTCs with anticancer immune cells or drugs.
Circulation times of cancer cells by in vivo flow cytometry

Li Zhang,Yan Li,Zhengqin Gu,Tong Chen,Cheng Wang,Xunbin Wei

DOI: https://doi.org/10.1117/12.911161

2012-01-01

Abstract:Liver cancer is one of the most common malignancies in the world, with approximately 1,000,000 cases reported every year. Hepatocellular carcinoma may metastasize to lung, bones, kidney, and many other organs. Surgical resection, liver transplantation, chemotherapy and radiation therapy are the foundation of current HCC therapies. However the outcomes are poor: the survival rate is almost zero for metastatic HCC patients. Molecular mechanisms of HCC metastasis need to be understood better and new therapies must be developed. A recently developed "in vivo flow cytometer" combined with real-time confocal fluorescence imaging are used to assess spreading and the circulation kinetics of liver tumor cells. The in vivo flow cytometer has the capability to detect and quantify continuously the number and flow characteristics of fluorescently labeled cells in vivo in real time without extracting blood sample. We have measured the depletion kinetics of two related human HCC cell lines, high-metastatic HCCLM3 cells and low-metastatic HepG2 cells, which were from the same origin and obtained by repetitive screenings in mice. >60% HCCLM3 cells are depleted within the first hour. Interestingly, the low-metastatic HepG2 cells possess noticeably slower depletion kinetics. In comparison, <40% HepG2 cells are depleted within the first hour. The differences in depletion kinetics might provide insights into early metastasis processes.
Real-Time Monitoring Of Rare Circulating Hepatocellular Carcinoma Cells In An Orthotopic Model By In Vivo Flow Cytometry Assesses Resection On Metastasis

Zhi-Chao Fan,Jun Yan,Guang-Da Liu,Xiao-Ying Tan,Xiao-Fu Weng,Wei-Zhong Wu,Jian Zhou,Xun-Bin Wei

DOI: https://doi.org/10.1158/0008-5472.CAN-11-3733

IF: 11.2

2012-01-01

Cancer Research

Abstract:The fate of circulating tumor cells (CTC) is an important determinant of metastasis and recurrence, which leads to most deaths in hepatocellular carcinoma (HCC). Therefore, quantification of CTCs proves to be an emerging tool for diagnosing, stratifying, and monitoring patients with metastatic diseases. In vivo flow cytometry has the capability to monitor the dynamics of fluorescently labeled CTCs continuously and noninvasively. Here, we combine in vivo flow cytometry technique and a GFP-transfected HCC orthotopic metastatic tumor model to monitor CTC dynamics. Our in vivo flow cytometry has approximately 1.8-fold higher sensitivity than whole blood analysis by conventional flow cytometry. We found a significant difference in CTC dynamics between orthotopic and subcutaneous tumor models. We also investigated whether liver resection promotes or restricts hematogenous metastasis in advanced HCC. Our results show that the number of CTCs and early metastases decreases significantly after the resection. The resection prominently restricts hematogenous metastasis and distant metastases. CTC dynamics is correlated with tumor growth in our orthotopic tumor model. The number and size of distant metastases correspond to CTC dynamics. The novel in vivo flow cytometry technique combined with orthotopic tumor models might provide insights to tumor hematogenous metastasis and guidance to cancer therapy. Cancer Res; 72(10); 2683-91. (C) 2012 AACR.
Circulation Times of Prostate Cancer and Hepatocellular Carcinoma Cells by in Vivo Flow Cytometry

Yan Li,Jin Guo,Chaofeng Wang,Zhichao Fan,Guangda Liu,Cheng Wang,Zhengqin Gu,David Damm,Axel Mosig,Xunbin Wei

DOI: https://doi.org/10.1002/cyto.a.21134

IF: 2.56

2010-01-01

Chinese Optics Letters

Abstract:Hepatocellular carcinoma (HCC) may metastasize to many organs. The survival rate is almost zero for metastatic HCC patients. Molecular mechanisms of HCC metastasis need to be understood better and new therapies must be developed. We have developed the "in vivo microscopy" to study the mechanisms that govern liver tumor cells spreading through the microenvironment in vivo. A recently developed "in vivo flow cytometer" combined with real-time confocal fluorescence imaging is used to assess spreading and the circulation kinetics of liver tumor cells. We measure the depletion kinetics of two related human HCC cell lines, high-metastatic HCCLM3 cells and low-metastatic HepG2 cells, which are from the same origin and obtained by repetitive screenings in mice. More than 60% of the HCCLM3 cells are depleted within the first hour. Interestingly, the low-metastatic HepG2 cells possess noticeably slower depletion kinetics. In comparison, less than 40% of the HepG2 cells are depleted within the first hour. The differences in depletion kinetics might provide insights into early metastasis processes.
Data from In Vivo Flow Cytometry

Irene Georgakoudi,Nicolas Solban,John Novak,William L. Rice,Xunbin Wei,Tayyaba Hasan,Charles P. Lin

DOI: https://doi.org/10.1158/0008-5472.c.6493608

2023-01-01

Abstract:<div>AbstractThe fate of circulating tumor cells is an important determinant of their ability to form distant metastasis. Here, we demonstrate the use of in vivo flow cytometry as a powerful new method for detecting quantitatively circulating cancer cells. We specifically examine the circulation kinetics of two prostate cancer cell lines with different metastatic potential in mice and rats. We find that the cell line and the host environment affect the circulation kinetics of prostate cancer cells, with the intrinsic cell line properties determining the initial rate of cell depletion from the circulation and the host affecting cell circulation at later time points.</div>

Studying Cancer Metastasis Potential by In-Vivo Flow Cytometry and Imaging

Studying leukemia metastasis by in vivo imaging and flow cytometer

Studying tumor metastasis by in vivo imaging and flow cytometer

Monitoring Hepatocellular Carcinoma Metastasis by in Vivo Flow Cytometer

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Studying Depletion Kinetics Of Circulating Prostate Cancer Cells By In Vivo Flow Cytometer

Monitoring Circulating Tumor Cells by In-Vivo Flow Cytometry

Studying Circulation Times of Liver Cancer Cells by in Vivo Flow Cytometry

In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

Monitoring Tumor Metastasis by in Vivo Imaging and Flow Cytometer

Applications of Optical in Vivo Flow Cytometry in Tumor Metastasis Research(Invited)

Advances of In Vivo Flow Cytometry on Cancer Studies

Studying leukemia metastasis and therapy monitoring by in vivo imaging and flow cytometer

Studying the Role of Macrophages in Circulating Prostate Cancer Cells by in Vivo Flow Cytometry

In Vivo Flow Cytometry Visualizes the Effects of Tumor Resection on Metastasis by Real-Time Monitoring of Rare Circulating Cancer Cells

Noninvasive and real-time monitoring of Au nanoparticle promoted cancer metastasis using in vivo flow cytometry

Visualizing Interactions of Circulating Tumor Cell and Dendritic Cell in the Blood Circulation Using in Vivo Imaging Flow Cytometry

Circulation times of cancer cells by in vivo flow cytometry

Real-Time Monitoring Of Rare Circulating Hepatocellular Carcinoma Cells In An Orthotopic Model By In Vivo Flow Cytometry Assesses Resection On Metastasis

Circulation Times of Prostate Cancer and Hepatocellular Carcinoma Cells by in Vivo Flow Cytometry

Data from &lt;b&gt;&lt;i&gt;In Vivo&lt;/i&gt;&lt;/b&gt; Flow Cytometry

Data from <b><i>In Vivo</i></b> Flow Cytometry